chevron_leftBack
As of 20 June 2026, Lukas Biomedical Inc. has a market cap of $33.5M USD, ranking #33470 globally and #2056 in Taiwan.
It ranks #3022 in the Healthcare sector, and #584 in the Biotechnology industry.
Key Stats
Market Cap
$33.5MUSD
1.06B TWD
Enterprise Value
$36.56MUSD
1.16B TWD
Revenue (TTM)
$5.7MUSD
180.32M TWD
EBITDA (TTM)
-$2.6MUSD
-82.3M TWD
Net Income (TTM)
-$3.04MUSD
-96.22M TWD
EBITDA Margin
-46%
Profit Margin
-53%
PS Ratio
5.9
PB Ratio
3.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Chaoan Liu
open_in_new
Employees
96
Founded
2002
Website
lukas-biomedical.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -8.5% | 2.1% | 1% | -11% | -7.5% | 3.3% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6814
路迦生醫股份有限公司 Ordinary Shares
ISIN: TW0006814007
Shares Out.:
Shares Outstanding:
41.874M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
24.10 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Lukas Biomedical Inc.
Lukas Biomedical Inc. engages in the wholesale and retail of cosmetics in Taiwan. The company operates through E-Commerce Department, Medical Management Business, Cell Products Department, and Pharmaceutical Market Development Department segments. It also researches and develops immune cell medical technology for regenerative medicine and adjuvant treatment; engages in clinical trials; distributes immune cell therapy culture technology; and leases building equipment. In addition, the company involved in the new immune cell research and development, new product development, clinical trials, and production of cell reagents; and provision of brand management and medical management services. Lukas Biomedical Inc. was founded in 2002 and is based in New Taipei City, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6919
|
$5.46B
16K%
172.76B TWD
|
-
|
|
TWSE: 6949
|
$1.61B
5K%
50.93B TWD
|
-
|
|
TPEX: 6696
|
$1.08B
3K%
34.04B TWD
|
-
|
|
TWSE: 7827
|
$726.25M
2K%
22.97B TWD
|
-
|
|
|
TPEX: 7827
|
$600.25M
2K%
18.98B TWD
|
-
|
|
TPEX: 06891
|
$571.26M
2K%
18.06B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
544K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
477K%
|
19.0
|
|
EBR: ARGX
|
$47.43B
141K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.23B
132K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.27B
126K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.88B
125K%
33.71B CHF
|
37.2
|
chevron_leftBack